Cargando…
Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open‐label, and single‐arm Phase 1 study
Autores principales: | Hannawi, Suad, Zhang, Rong‐Rong, Abuquta, Alaa, Safeldin, Linda, Hassan, Aala, Alamadi, Ahmad, Hossain, Tasmiah, Mostafa, Mohamed, Ghoneim, Yasser, Solo, Jennifer, Zheng, Hong‐Xia, Wu, Ding‐Feng, Yu, Dan‐Dan, Yuan, Jia‐Cheng, Zhao, Di, Lin, Rui, Ying, Bo, Qin, Cheng‐Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447877/ https://www.ncbi.nlm.nih.gov/pubmed/37612802 http://dx.doi.org/10.1002/ctm2.1387 |
Ejemplares similares
-
Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial
por: Hannawi, Suad, et al.
Publicado: (2022) -
Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial
por: Hannawi, Suad, et al.
Publicado: (2023) -
Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial
por: Hannawi, Suad, et al.
Publicado: (2022) -
Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
por: Hannawi, Suad, et al.
Publicado: (2023) -
Omicron entry route
por: Pia, Luisanna, et al.
Publicado: (2022)